Get the Stockscreener App
0.825
3.71%
0.0295
After Hours:
2.59
1.765
+213.94%
Dyadic International Inc De stock is traded at $0.825, with a volume of 9,470.
It is up +3.71% in the last 24 hours and down -11.02% over the past month.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$0.7955
Open:
$0.81
24h Volume:
9,470
Relative Volume:
0.04
Market Cap:
$29.85M
Revenue:
$4.14M
Net Income/Loss:
$-5.58M
P/E Ratio:
-4.4283
EPS:
-0.1863
Net Cash Flow:
$-2.98M
1W Performance:
-2.88%
1M Performance:
-11.02%
6M Performance:
-2.94%
1Y Performance:
-47.78%
1-Day Range:
$0.81
$0.852
1-Week Range:
$0.7955
$0.864
52-Week Range:
$0.711
$1.73
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.22 | 3.25B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.69 | 536.01M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.32 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.8999 | 277.51M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
46.01 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Resumed | H.C. Wainwright | Buy |
| Sep-08-25 | Initiated | Craig Hallum | Buy |
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Dyadic International (NASDAQ:DYAI) Stock Passes Below Fifty Day Moving Average – Should You Sell? - Defense World
Dyadic International (NASDAQ:DYAI) Share Price Crosses Below 50 Day Moving Average – Should You Sell? - Defense World
Dyadic International’s Tiny Stock, Big Volatility: Can DYAI’s Latest Rally Really Last? - AD HOC NEWS
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Dyadic International Inc. (NASDAQ:DYAI) Short Interest Up 25.7% in December - Defense World
iAccess Alpha’s Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Ventura County Star
Dyadic International Amends Convertible Notes, Extends Maturity Timeline - TipRanks
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic International receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com UK
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets - GlobeNewswire
Analysis of Market Segmentation, Major Trends, and Competitive Dynamics in the Cellulase Market - openPR.com
Dyadic Applied BioSolutions Establishes Commercial - GlobeNewswire
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins - Yahoo Finance
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Finviz
Earnings call transcript: Dyadic’s Q3 2025 results miss forecasts, stock dips - Investing.com
Earnings call transcript: Dyadic's Q3 2025 results miss forecasts, stock dips - Investing.com UK
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Dyadic International’s CRISPR Leap: Future Unveiled - timothysykes.com
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - News & Observer
Dyadic (DYAI) and BRIG BIO ink alpha-lactalbumin pact for global nutrition - Stock Titan
DYAIDyadic International Inc., DE Stock Price and Quote - Finviz
Will Dyadic International Inc. stock beat EPS estimatesJuly 2025 Volume & Verified Stock Trade Ideas - moha.gov.vn
Taking on analysts’ expectations and winning: Apyx Medical Corp (APYX) - Setenews
A Look at Greenidge Generation Holdings Inc (GREE) Shares in the Recent Past Indicates Growth - Setenews
Bandera Partners LLC Has $1.37 Million Holdings in Dyadic International Inc. $DYAI - Defense World
AXQ Capital LP Sells 411 Shares of Acuity, Inc. $AYI - Defense World
What momentum shifts mean for Dyadic International Inc.Trade Volume Summary & Weekly Top Gainers Alerts - newser.com
Dyadic International’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
Dyadic (DYAI) Q3 2025 Earnings Call Transcript - AOL.com
Dyadic International Inc (DYAI) Q3 2025 Earnings Call Highlights: Transition to Commercial ... By GuruFocus - Investing.com Canada
Dyadic Applied BioSolutions Reports Q3 2025 Earnings and Strategic Shift - TipRanks
Earnings call transcript: Dyadic International Q3 2025 sees revenue miss, stock dips - Investing.com Australia
Dyadic (NASDAQ: DYAI) rebrands, shifts to commercial focus; third‑quarter revenue $1.165M - Stock Titan
Dyadic International Inc (DYAI) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Dyadic International (DYAI) to Release Earnings on Wednesday - Defense World
Dyadic International, ERS Genomics announces CRISPR/Cas9 license - TipRanks
Dyadic (DYAI) gains access to ERS’ 100+ CRISPR/Cas9 patents to speed strain engineering - Stock Titan
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics - Yahoo Finance
TOYO Co Ltd (TOYO): What Does Valuation Ratios Tell Us? - fostersleader.com
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):